Atsena Therapeutics is a clinical-stage gene therapy company focused on reversing or preventing blindness from inherited retinal diseases

Boomerang Medical is a bioelectronic medicine company developing neuromodulation technologies to treat autoimmune diseases

CREATE Medicines is a clinical-stage biotechnology company pioneering a new class of in vivo immune programming therapies

Endogenex is a clinical-stage medical technology company developing a novel, minimally invasive endoscopic procedure for people with type 2 diabetes.

GeneCentric’s mission is to address the urgent unmet need in precision oncology for better biomarkers and to bring these biomarkers to liquid biopsies.

HistoSonics, Inc. is pioneering a novel, non-invasive therapeutic platform based on histotripsy. Acquired by Bezos Expeditions, Wellington K5 Global 2025

Perfuse Therapeutics is a clinical-stage biopharmaceutical company developing first-in-class therapies to improve retinal blood flow and treat ischemia-driven eye diseases.

RapidPulse is a medical device company developing an innovative, minimally invasive vascular system for treating acute ischemic stroke.

Tune Therapeutics is a biotechnology innovator advancing a new class of epi-therapeutic medicines
